Last update Sept. 17, 2022
Metaxalone is a centrally acting skeletal muscle relaxant. It has sedative properties. Oral administration three or four times a day.
Since the last update we have not found published data on its excretion in breastmilk.
Its large volume of distribution could limit its excretion in breast milk.
Its effectiveness. is very limited. (Chou 2004)
Product with very few bibliographical references and marketed in very few countries.
Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable, especially during the neonatal period and in the event of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM